Journal
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
Volume 62, Issue 6, Pages 395-404Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1369/0022155414530995
Keywords
cannabinoid; CB2; immunoblot; mass spectrometry; membrane enrichment; western blot
Categories
Funding
- Marsden Fund of New Zealand
- IRG Marie-Curie Fellowship (NGINFAD)
Ask authors/readers for more resources
Antibody-based methods for the detection and quantification of membrane integral proteins, in particular, the G protein-coupled receptors (GPCRs), have been plagued with issues of primary antibody specificity. In this report, we investigate one of the most commonly utilized commercial antibodies for the cannabinoid CB2 receptor, a GPCR, using immunoblotting in combination with mass spectrometry. In this way, we were able to develop powerful negative and novel positive controls. By doing this, we are able to demonstrate that it is possible for an antibody to be sensitive for a protein of interestin this case CB2but still cross-react with other proteins and therefore lack specificity. Specifically, we were able to use western blotting combined with mass spectrometry to unequivocally identify CB2 protein in over-expressing cell lines. This shows that a common practice of validating antibodies with positive controls only is insufficient to ensure antibody reliability. In addition, our work is the first to develop a label-free method of protein detection using mass spectrometry that, with further refinement, could provide unequivocal identification of CB2 receptor protein in native tissues.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available